Table 2.
Variables | 28–167 cDDD |
⩾168 cDDD |
||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |||
Main modela | 0.98 | 0.93 | 1.03 | 0.3307 | 0.65 | 0.62 | 0.69 | <0.0001 |
Additional covariatesb | ||||||||
Main model + Severity of depression | 0.97 | 0.92 | 1.02 | 0.2917 | 0.65 | 0.62 | 0.68 | <0.0001 |
Main model + ADs use within 1 year before Index date | 0.93 | 0.88 | 0.98 | 0.0074 | 0.61 | 0.58 | 0.64 | <0.0001 |
Main model + CCI | 0.97 | 0.92 | 1.02 | 0.2287 | 0.66 | 0.62 | 0.69 | <0.0001 |
Main model + Coronary artery disease | 0.97 | 0.92 | 1.02 | 0.2847 | 0.65 | 0.62 | 0.68 | <0.0001 |
Main model + Heart failure | 0.98 | 0.93 | 1.03 | 0.3990 | 0.66 | 0.63 | 0.69 | <0.0001 |
Main model + End stage renal disease | 0.98 | 0.93 | 1.03 | 0.3532 | 0.65 | 0.62 | 0.69 | <0.0001 |
Main model + Chronic obstructive pulmonary disease | 0.98 | 0.93 | 1.03 | 0.3320 | 0.66 | 0.63 | 0.69 | <0.0001 |
Main model + Malignancy | 0.97 | 0.92 | 1.02 | 0.2156 | 0.65 | 0.62 | 0.68 | <0.0001 |
Main model + Diabetes | 0.97 | 0.92 | 1.02 | 0.2515 | 0.65 | 0.62 | 0.69 | <0.0001 |
Main model + Hypertension | 0.98 | 0.93 | 1.03 | 0.3284 | 0.65 | 0.62 | 0.68 | <0.0001 |
Main model + Donepezil | 0.98 | 0.93 | 1.03 | 0.3856 | 0.66 | 0.63 | 0.69 | <0.0001 |
Main model + Rivastigmine | 0.98 | 0.93 | 1.03 | 0.3852 | 0.66 | 0.63 | 0.69 | <0.0001 |
Main model + Galantamine | 0.98 | 0.93 | 1.03 | 0.3499 | 0.65 | 0.62 | 0.69 | <0.0001 |
Main model + Memantine | 0.98 | 0.93 | 1.03 | 0.3467 | 0.66 | 0.63 | 0.69 | <0.0001 |
Subgroup effects | ||||||||
Gender | ||||||||
Male | 0.96 | 0.90 | 1.03 | 0.2914 | 0.64 | 0.60 | 0.68 | <0.0001 |
Female | 0.99 | 0.92 | 1.07 | 0.8169 | 0.67 | 0.62 | 0.72 | <0.0001 |
Age (year) | ||||||||
60–80 | 0.99 | 0.92 | 1.06 | 0.7021 | 0.63 | 0.59 | 0.67 | <0.0001 |
>80 | 0.96 | 0.89 | 1.03 | 0.2580 | 0.68 | 0.63 | 0.73 | <0.0001 |
Severity of depression | ||||||||
Major depression | 0.92 | 0.83 | 1.03 | 0.1557 | 0.56 | 0.51 | 0.62 | <0.0001 |
Minor depression | 0.98 | 0.92 | 1.04 | 0.4046 | 0.68 | 0.64 | 0.72 | <0.0001 |
ADs use within 1 year before Index date | ||||||||
Yes | 0.94 | 0.86 | 1.03 | 0.1835 | 0.60 | 0.55 | 0.66 | <0.0001 |
No | 0.92 | 0.86 | 0.98 | 0.0138 | 0.61 | 0.57 | 0.66 | <0.0001 |
Main model was adjusted for gender, age, urbanization, income, and year of index date.
The models were adjusted for covariates in the main model as well as each additional listed covariate.
cDDD: cumulative defined daily dosage; HR: hazard ratio; CI: confidence interval; ADs: antidepressants; CCI: Charlson comorbidity index.